About BioIntelliSense
BioIntelliSense is a Healthcare company based in Redwood City (United States) founded in 2018 by David Wang and James Mault. Vital signs are monitored via a single-use patch and platform. It operates in the Healthcare and Technology sectors. BioIntelliSense has raised $140.05 million across 4 funding rounds from investors including Philips, UCHealth and Fresenius Medical Care. The company has 26 employees. BioIntelliSense has completed 1 acquisition, including AlertWatch. Its chief executive, as recorded, is David Wang. Its focus areas include HealthTech, Healthcare IT, Value Based Care and Remote Monitoring. Its legal entity is BIOINTELLISENSE INC. Its competitors include iHealth Labs, Endotronix and Biotricity; 2 of its 3 listed competitors have raised funding.
Company details
BioIntelliSense was established in 2018 in Redwood City, United States, within the healthcare technology sector. A single-use patch is developed for continuous vital signs monitoring, alongside a data-as-a-service platform, smart button, and smart sticker. These tools capture health data from a device attached to the upper left chest, enabling remote oversight by healthcare providers for patient management. Operations focus on integrating hardware with digital analytics for clinical use.
- Headquarters Redwood City, United States
- Employees 26
- Founders David Wang, James Mault
- SectorsHealthcareTechnology
- Email••••••••
- Website biointellisense.com
- Social LinkedIn X
- Legal Name Biointellisense Inc
- Total Equity Funding$140.05M (USD)
in 4 rounds
- Latest Funding Round$58.05M (USD), Series C
Dec 2025
- InvestorsPhilips
& 9 more
- Employee Count26
- Investments & Acquisitions
Funding Insights of BioIntelliSense
BioIntelliSense has successfully raised a total of $140.05M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $58.05 million completed in December 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $140.05M
- Total Rounds 4
- Last Round Series C — $58.05M
- First Round $25M
(Dec 2018)
- Investors Count 10
All 4 funding rounds of BioIntelliSense with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2025 | $58.05M | Series C | – | – | – |
| Jul 2021 | $45M | Series B | – | Chimera | |
| Aug 2020 | $12M | Series B | – | – | – |
| Dec 2018 | $25M | Series B | – | – | – |
10 investors in total: 8 institutional and 2 angel.
Investors in BioIntelliSense
BioIntelliSense has secured backing from 10 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Philips, UCHealth and Fresenius Medical Care.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A private investment firm focused on regional opportunities. | chimerainvestment.com | Abu Dhabi, United Arab Emirates | ||
Tech focused early stage VC firm investing primarily in the US | 7wireventures.com | Chicago, United States | ||
Venture capital fund focused on multiple sectors | pendrell.com | Kirkland, United States | ||
| cuvcfund.com | ||||
Fresenius Medical Care is engaged in providing kidney care and dialysis solutions. | 1996 | fmcna.com | Waltham, United States | |
Healthcare-focused investment banking services are offered by Triple Tree. | 1997 | triple-tree.com | Minneapolis, United States | |
Chain of multispeciality hospitals | 1921 | uchealth.org | United States | |
Diversified products are provided across health, lighting, and consumer sectors. | 1891 | philips.com | Amsterdam, Netherlands | |
MT Mary Tolan | Founder of Accretive Health, active angel investor in healthcare and tech startups. | unknown_59cae3dda7d446aea | ||
JM James Murren | Indian angel investor with focus on early-stage startups and technology ventures. | unknown_4fc8cf5c4e9c48778 |
Investor details for BioIntelliSense
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of BioIntelliSense
31 people are tracked at BioIntelliSense (17 in leadership, 14 in team); the tracked headcount is 26.
| Name | Role | Group |
|---|---|---|
David Wang | Co-Founder & CEO | Leadership |
James Mault | Co-Founder | Leadership |
Josh Miller | COO | Leadership |
Jace Blackburn | Head Of Product Management | Leadership |
Henry Leung | Sr Director Technical Product / System Engineering | Leadership |
Dnyanesh Sonavane | Sr Director Of Data Engineering | Leadership |
Brian Demcher | Director Of Client Strategy & Growth | Leadership |
Alexander Katsis | Director Of Sensors & Algorithms | Leadership |
Jennifer King | Executive Project Specialist To The CEO | Leadership |
Greg Weaver | CFO | Leadership |
Rafael Santana | Vice President, Devices And Systems | Leadership |
Justin Rice | Vice President, Portfolio & PMO | Leadership |
Marshal Dhillon | Senior Vice President Of Engineering | Leadership |
Kate Hale | Director Of Integrated Supply Chain And Manufacturing Services | Leadership |
Frank O'Neill | Director Systems Engineering | Leadership |
Yusi Liu | Head Of Regulatory Affairs And Quality Assurance (ra & Qa); Management Representative | Leadership |
Daniel Chou | Director Of Cloud Engineering | Leadership |
Konstantin A. | Senior Firmware Engineer | Team |
Shayan G. | Sr. Embedded Algorithms Engineer | Team |
Ray Hsieh | Sustaining Manager, Implementation | Team |
11 more people are available in the full profile.
Complete people profiles for BioIntelliSense
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioIntelliSense
BioIntelliSense has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include AlertWatch.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Real-time patient monitoring software is provided for acute care clinicians. | alertwatch.com | Ann Arbor, United States | 2011 | Oct 2022 | •••• |
Complete acquisition details for BioIntelliSense
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of BioIntelliSense
4 dated milestones of BioIntelliSense across 7 years, from founding to its latest funding, stage changes and deals.
- Founded BioIntelliSense is founded.
- Funding First funding round of $25.0M.
- Acquisition Acquires AlertWatch.
- Funding Latest funding round, Series C, of $58.1M.
Competitors of BioIntelliSense
BioIntelliSense has 3 listed competitors in our database, 2 of them funded. They include iHealth Labs, Endotronix and Biotricity.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ihealthlabs.com | 2010 | Mountain View, United States | $25M | 104 | Personal healthcare devices for vital monitoring are designed and produced. | |
| endotronix.com | 2007 | East Peoria, United States | $154.77M | 104 | Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | |
| biotricity.com | 2014 | San Francisco, United States | 55 | Developer of medical remote monitoring solutions that help prevent and manage chronic diseases |
Detailed competitors of BioIntelliSense
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of BioIntelliSense
The website of BioIntelliSense (biointellisense.com) receives about 4K visits a month.
- Monthly visits4K
▲ 93.6% vs previous month
Websites whose visitors overlap most with BioIntelliSense. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| thehealthcaretechnologyreport.com | 100% | #1,012,018 | View details | ||
| freseniusmedicalcare.com | 100% | 523.8K | #109,578 | View details | |
| massdevice.com | 100% | #435,992 | View details |
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as BioIntelliSense (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biointellisense
Complete news archive for BioIntelliSense
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioIntelliSense
BioIntelliSense was founded in 2018.
BioIntelliSense is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
David Wang is the CEO of BioIntelliSense, as recorded in our data. They have also founded this company.
BioIntelliSense is a funded company, having raised a total of $140.05M across 4 funding rounds to date. The company's 1st funding round was a Series B of $25M, raised on Dec 2018.
BioIntelliSense has 26 employees.
BioIntelliSense was established in 2018 in Redwood City, United States, within the healthcare technology sector. A single-use patch is developed for continuous vital signs monitoring, alongside a data-as-a-service platform, smart button, and smart sticker. These tools capture health data from a device attached to the upper left chest, enabling remote oversight by healthcare providers for patient management. Operations focus on integrating hardware with digital analytics for clinical use.
BioIntelliSense's top competitors include Endotronix, iHealth Labs and Biotricity.
BioIntelliSense has made 1 acquisition, including AlertWatch.
BioIntelliSense has 10 investors. Key investors include Philips, UCHealth, Fresenius Medical Care, Triple Tree, and Chimera Investment.
BioIntelliSense operates through Biointellisense Inc.